Published in
Elsevier, European Journal of Cancer, 16(48), p. 3063-3072, 2012
DOI: 10.1016/j.ejca.2012.05.020
Links
Tools
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial
Journal article published in 2012 by
G. J. Veal 
,
L. Nguyen,
A. Paci,
M. Riggi,
M. Amiel,
D. Valteau-Couanet,
P. Brock,
R. Ladenstein,
G. Vassal
,
L. Nguyen,
A. Paci,
M. Riggi,
M. Amiel,
D. Valteau-Couanet,
P. Brock,
R. Ladenstein,
G. Vassal
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 